Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Authors
Keywords
-
Journal
PPAR Research
Volume 2023, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2023-06-27
DOI
10.1155/2023/8456833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis and Treatment of Chronic Lymphocytic Leukemia
- (2023) Mazyar Shadman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
- (2022) Elliot D. Mock et al. PROGRESS IN LIPID RESEARCH
- Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model
- (2022) Xin Zhang et al. Biomarker Research
- T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
- (2021) Fleur S. Peters et al. HAEMATOLOGICA
- Current and future treatment strategies in chronic lymphocytic leukemia
- (2021) Krish Patel et al. Journal of Hematology & Oncology
- Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
- (2021) Michael Hallek et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia
- (2020) Jimmy Lee et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
- (2018) Michael Hallek et al. BLOOD
- Knowledge database assisted gene marker selection for chronic lymphocytic leukemia
- (2018) Xixi Xiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Comprehensive literature data-mining analysis reveals a broad genetic network functionally associated with autism spectrum disorder
- (2018) Cheng Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells
- (2017) B Yigit et al. LEUKEMIA
- Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists
- (2016) Alessandra Ammazzalorso et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PPARα regulates tumor progression, foe or friend?
- (2015) Jiaming Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Unknown
- (2015) Davorka Messmer et al. MOLECULAR MEDICINE
- Toll-Like Receptors in Human Multiple Myeloma: New Insight into Inflammation-Related Pathogenesis
- (2014) J. Abdi et al. CURRENT MOLECULAR MEDICINE
- PPAR and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
- (2013) S. Tung et al. BLOOD
- Activation of the NOTCH1 pathway in chronic lymphocytic leukemia
- (2012) V. Gianfelici HAEMATOLOGICA
- PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
- (2012) D E Spaner et al. LEUKEMIA
- Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia
- (2010) M Shehata et al. LEUKEMIA
- Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype
- (2009) Barbara Tolusso et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started